Observational Study to Evaluate the Actual Use and Effectiveness of Dymista® Nasal Spray in Asian Patients

CompletedOBSERVATIONAL
Enrollment

924

Participants

Timeline

Start Date

October 27, 2021

Primary Completion Date

October 24, 2023

Study Completion Date

October 24, 2023

Conditions
Allergic Rhinitis
Interventions
DRUG

Dymista

1 spray per nostril twice daily up to four weeks

Trial Locations (33)

31400

Pantai Hospital Ipoh, Perai

Unknown

Hong Kong ENT Clinic, Hong Kong

Asia Priority Healthcare, Kowloon

Kempas Medical Center, Johor Bahru

KPJ Johor Specialist Hospital, Johor Bahru

Allergy and Immunology Clinic Gleneagles Kuala Lumpur, Kuala Lumpur

University Malaya Medical Centre, Kuala Lumpur

Hospital Universiti Sains Malaysia, Kubang Kerian

Sarawak General Hospital, Kuching

Hospital Sultan Abdul Aziz Shah, Serdang

St. Martin De Porres Hospital, Chiayi City

Chang Gung Memorial Hospital-KAOHSIUNG, Kaohsiung City

Asia University Hospital, Taichung

China Medical University Hospital, Taichung

Taichung Veterans General Hospital, Taichung

National Taiwan University Hospital, Taipei

Taipei Medical University Hospital, Taipei

Taipei Municipal Wan Fang Hospital, Taipei

China Medical University Hsinchu Hospital, Zhubei

Bangkok hospital, Bangkok

King Chulalongkorn Memorial Hospital (Department of Medicine), Bangkok

King Chulalongkorn Memorial Hospital (Department of Pediatrics), Bangkok

King Chulalongkorn Memorial Hospital, Bangkok

Phramongkutklao Hospital, Bangkok

Rajavithi Hospital, Bangkok

Ramathibodi hospital, Bangkok

Siriraj Hospital (Department of Medicine), Bangkok

Siriraj Hospital (Department of Otorhinolaryngology), Bangkok

Thammasat University Hospital (Department of Otolaryngology), Bangkok

Thammasat University Hospital (Department of Pediatrics), Bangkok

Maharaj Nakorn Chiang Mai Hospital, Chiang Mai

Naresuan University Hospital, Phitsanulok

Songkla University Hospital, Songkhla

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

MEDA Pharma GmbH & Co. KG

INDUSTRY

lead

Mylan Inc.

INDUSTRY